Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: Case-control study Academic Article uri icon

Overview

MeSH Major

  • Mass Screening
  • Prostate-Specific Antigen
  • Prostatic Neoplasms

abstract

  • Measurement of PSA concentration in early midlife can identify a small group of men at increased risk of prostate cancer metastasis several decades later. Careful surveillance is warranted in these men. Given existing data on the risk of death by PSA concentration at age 60, these results suggest that three lifetime PSA tests (mid to late 40s, early 50s, and 60) are probably sufficient for at least half of men.

publication date

  • May 11, 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3933251

Digital Object Identifier (DOI)

  • 10.1136/bmj.f2023

PubMed ID

  • 23596126

Additional Document Info

start page

  • f2023

volume

  • 346

number

  • 7907